Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer.

Danieli-Mackay A, Papadionysiou I, Tsitsianopoulos M, Gätje FB, Spahn H, Schmidt C, Klein L, Ramasamy S, Übelmesser N, Appelhans J, Dschun O, Duman ET, Ludewig F, Schimkowiak S, Dobbelstein M, Salinas G, Ströbel P, Oudelaar AM, De Oliveira T, Singh SK, Längst G, Conradi LC, Papantonis A

Open source

DOI
10.1016/j.celrep.2026.117649
Published
2026 Sep 22
Container
Cell reports
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.celrep.2026.117649,
  title = {Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer.},
  author = {Danieli-Mackay A and Papadionysiou I and Tsitsianopoulos M and Gätje FB and Spahn H and Schmidt C and Klein L and Ramasamy S and Übelmesser N and Appelhans J and Dschun O and Duman ET and Ludewig F and Schimkowiak S and Dobbelstein M and Salinas G and Ströbel P and Oudelaar AM and De Oliveira T and Singh SK and Längst G and Conradi LC and Papantonis A},
  year = {2026},
  journal = {Cell reports},
  doi = {10.1016/j.celrep.2026.117649},
  url = {https://doi.org/10.1016/j.celrep.2026.117649}
}

RIS

TY  - JOUR
TI  - Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer.
AU  - Danieli-Mackay A
AU  - Papadionysiou I
AU  - Tsitsianopoulos M
AU  - Gätje FB
AU  - Spahn H
AU  - Schmidt C
AU  - Klein L
AU  - Ramasamy S
AU  - Übelmesser N
AU  - Appelhans J
AU  - Dschun O
AU  - Duman ET
AU  - Ludewig F
AU  - Schimkowiak S
AU  - Dobbelstein M
AU  - Salinas G
AU  - Ströbel P
AU  - Oudelaar AM
AU  - De Oliveira T
AU  - Singh SK
AU  - Längst G
AU  - Conradi LC
AU  - Papantonis A
PY  - 2026
JO  - Cell reports
DO  - 10.1016/j.celrep.2026.117649
UR  - https://doi.org/10.1016/j.celrep.2026.117649
ER  - 

APA

A, D., I, P., M, T., FB, G., H, S., C, S., L, K., S, R., N, Ü., J, A., O, D., ET, D., F, L., S, S., M, D., G, S., P, S., AM, O., T, D. O., SK, S., G, L., LC, C., & A, P. (2026). Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer.. Cell reports. https://doi.org/10.1016/j.celrep.2026.117649

Source records